Reminder: Invitation to Roche ’s virtual Analyst and Investor Event on Diagnostics Division at AACC 2022

 We are pleased to invite you to a virtual analyst and investor event onTuesday, 26 July 2022, to discuss Roche ’s Diagnostics Division, in conjunction with the American Association for Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Exposition in Chicago, Illinois (July 24-28, 2022).Please note that since the overwhelming majority of registrations was for a virtual participation, it has been decided to switch the event to a virtual formatonly(no on site event).6:00 - 7:15 pm CDT / 7:00 - 8:15 pm EDT / 4:00 - 5:15 pm PDTAACC brings together the global leaders in clinical chemistry, molecular diagnostics and lab management, and is the largest dedicated exhibition of equipment, instruments and services for clinical laboratories in the world.The webinar will start with a presentation on the Diagnostics Division and on AACC highlights followed by a Q&A session (live access to the speakers). Thepresentation slides will be available for download from the IR website at 5:00pm CDT on the day of the event.>click here.Presenters: Thomas Schinecker, CEO Roche DiagnosticsAnn Costello, Global Head Roche Diagnostics SolutionsCindy Perettie, Head of Molecular LabsMatt Sause, President and CEO Roche Diagnostics, North AmericaPalani Kumaresan, Global Head of R&D Roche Diagnostics Solutions Access to virtual event (pre-registration required)Please pre-register for our webinarhere.* Should you be unable to register for the webinar due to your company I...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news